Singapore HSA approves Pfizer-BioNTech’s shot for children
The expert committee also recommended the usage of booster shot to inoculate adults aged 18 to 29 years.
Singapore
Latest in
Singapore
Novavax seeks interim authorisation for Covid-19 vaccine in Singapore
The company’s filing includes positive clinical data from two Phase III trials.
Sen-Jam and Duke-NUS to initiate Phase II Covid-19 therapy trial in Nepal
A combination of a non-steroidal anti-inflammatory drug and antihistamine, SJP-002C can potentially prevent SARS inflammation.
Seagen and RemeGen enter up to $2.6bn deal for cancer drug
Disitamab vedotin uses a combination of Seagen’s drug-linker technology with a new HER2 antibody of RemeGen.
Singapore’s GIC to invest $1bn in Grifols subsidiary Biomat
The proceeds from the GIC investment will be used to pay off the debt and grow Grifols’s US plasma centre…
Moderna’s Covid-19 vaccine receives interim authorisation in Singapore
The Singapore Health Sciences Authority (HSA) has approved the interim authorisation of Moderna’s mRNA Covid-19 vaccine for use under the…
Singapore approves Pfizer and BioNTech’s Covid-19 vaccine
Singapore has approved the Covid-19 vaccine by Pfizer and its German partner BioNTech, as well as expects delivery of the…
Singapore approves Gilead’s remdesivir to treat Covid-19
Singapore's Health Sciences Authority (HSA) has awarded conditional approval for Gilead Sciences Singapore's experimental antiviral drug remdesivir, under the brand…